Mycobacterium vaccae
Vaccineexperimental
Clinical trial activity
5 trials · 7 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
2
Phase 3
2
Phase 4
2
Earliest trial started Mar 1, 1995 (NCT00367913)
Timeline
Indications
Approved for
Mechanism of action
- MycobacteriumImmunity, active
Mycobacterium immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- m. vaccae.
- srl-172
- vaccae
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06800963 | Phase 1/Phase 2 (Phase 2) | May 31, 2025 | ImmunityBio, Inc. |
| NCT05680415 | Phase 4 | Apr 19, 2023 | Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd., Government of China |
| NCT01979900 | Phase 3 | Oct 1, 2013 | Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd., Government of China, People's Liberation Army of China |
| NCT00052195 | Phase 2/Phase 3 (Phase 3) | Sep 1, 2001 | Dartmouth University, National Institute of Allergy and Infectious Diseases (NIAID) |
| NCT00367913 | Phase 4 | Mar 1, 1995 | British Thoracic Society |
Showing 5 of 5 trials
Page 1 / 1
Organizations
Research & Development (7)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. | For profit | 2 | 2 | 2 | 2013 |
| Government of China | Government | 2 | 0 | 2 | 2013 |
| British Thoracic Society | Academic/Hospital | 1 | 1 | 1 | 1995 |
| Dartmouth University | Academic/Hospital | 1 | 1 | 1 | 2001 |
| ImmunityBio, Inc. | For profit | 1 | 1 | 1 | 2025 |
| National Institute of Allergy and Infectious Diseases (NIAID) | Government | 1 | 0 | 1 | 2001 |
| People's Liberation Army of China | Government | 1 | 0 | 1 | 2013 |
7 organizations
Page 1 / 1